Spirea Limited (09817891) is a private limited with share capital incorporated on 09/10/2015 (10 years old) and registered in harrogate, HG12PW. The company operates under SIC code 63990 and is classified as Micro.
Spirea limited is a cambridge-based company created to advance a new generation of antibody-targeted cancer treatments with significantly better efficacy and safety profiles. spirea will use its innovative technology to enable a pipeline of superior and differentiated antibody drug conjugates for th...
Appoint Corporate Secretary Company With Name Date
Category:Officers
Date:26-03-2020
Appoint Person Director Company With Name Date
Category:Officers
Date:19-03-2020
Termination Secretary Company With Name Termination Date
Category:Officers
Date:18-03-2020
Appoint Person Director Company With Name Date
Category:Officers
Date:16-03-2020
Appoint Person Director Company With Name Date
Category:Officers
Date:13-03-2020
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:13-03-2020
Resolution
Category:Resolution
Date:24-12-2019
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:24-10-2019
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:18-07-2019
Termination Director Company With Name Termination Date
Category:Officers
Date:02-05-2019
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:21-03-2019
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:19-10-2018
Resolution
Category:Resolution
Date:03-10-2018
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:10-08-2018
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:01-08-2018
Appoint Corporate Secretary Company With Name Date
Category:Officers
Date:10-04-2018
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:10-04-2018
Appoint Corporate Director Company With Name Date
Category:Officers
Date:23-02-2018
Resolution
Category:Resolution
Date:23-02-2018
Confirmation Statement With Updates
Category:Confirmation Statement
Date:09-10-2017
Accounts With Accounts Type Dormant
Category:Accounts
Date:06-07-2017
Change Person Director Company With Change Date
Category:Officers
Date:24-11-2016
Confirmation Statement With Updates
Category:Confirmation Statement
Date:24-11-2016
Capital Allotment Shares
Category:Capital
Date:17-05-2016
Resolution
Category:Resolution
Date:12-05-2016
Change Person Director Company With Change Date
Category:Officers
Date:04-11-2015
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:04-11-2015
Incorporation Company
Category:Incorporation
Date:09-10-2015
Innovate Grants
2
This company received a grant of £474695.0 for The Development Of A New First-In-Class Cancer Therapeutic For Difficult-To-Treat Metastatic Triple Negative Breast. The project started on 01/11/2025 and ended on 30/06/2027.
This company received a grant of £104123.0 for Development Of Advanced Therapies In Cancer Using A High Loaded Targeted Delivery Platform. The project started on 01/01/2018 and ended on 31/03/2019.